Stay updated with breaking news from Research Models. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com upgraded shares of Charles River Laboratories International (NYSE:CRL – Free Report) from a hold rating to a buy rating in a research report released on Friday morning. A number of other analysts have also issued reports on CRL. Credit Suisse Group reduced their target price on Charles River Laboratories International from $260.00 to $255.00 […]
Izotropic (OTCMKTS:IZOZF – Get Free Report) and Inotiv (NASDAQ:NOTV – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, profitability, earnings and analyst recommendations. Profitability This table compares Izotropic and Inotiv’s net margins, return […]
Spire Wealth Management lessened its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 25.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,236 shares of the medical research company’s stock after selling 427 shares during […]
StockNews.com started coverage on shares of Charles River Laboratories International (NYSE:CRL – Free Report) in a report published on Thursday. The firm issued a hold rating on the medical research company’s stock. A number of other analysts also recently weighed in on CRL. TheStreet downgraded shares of Charles River Laboratories International from a b- rating […]
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) VP William D. Barbo sold 5,763 shares of the firm’s stock in a transaction that occurred on Thursday, August 10th. The stock was sold at an average price of $217.24, for a total transaction of $1,251,954.12. Following the sale, the vice president now owns 3,592 […]